Technology
The all-cash transaction will see Cross Country transition to a privately held company with its common stock no longer trading on the Nasdaq.
The integration will give long-term and post-acute care providers access to tools designed to improve patient outcomes and streamline care management.
Vitality Program participants receive other rewards and discounts, such as savings on life insurance premiums.
The company will use the funds to support its ongoing clinical trial, ramp up production and sales for its OtoSight Middle Ear Scope and relocate its headquarters.
The announcement comes two months after the pair revealed at the UN General Assembly its intent to expand Zipline infrastructure to improve care access nationwide.
The company says 510(k) clearance will allow it to pursue multiple business opportunities pertaining to remote patient monitoring and clinical trials.
The patent includes the company's safety-focused LLMs incorporated into its Polaris constellation architecture.
The announcement comes about four months after Musk relayed his vision for patients with an Optimus robotic arm or leg to have the ability to control their limbs with the N1 implant.
The funds will be used to strengthen the company's platform with AI-driven features, increase its product development and meet rising market demand for digital healthcare.
The AI models only utilise wearable sleep and circadian rhythm data to analyse patterns driving mood disorders.